Inhibition of aquaporin-3 in macrophages by a monoclonal antibody as potential therapy for liver injury
Aquaporin 3 (AQP3) is a transporter of water, glycerol and hydrogen peroxide, and hydrogen peroxide mediated oxidative stress has been implicated in liver injury. Here, the authors report the development of an anti-AQP3 monoclonal antibody, which alleviates liver injury in multiple mouse models.
Guardado en:
Autores principales: | Mariko Hara-Chikuma, Manami Tanaka, Alan S. Verkman, Masato Yasui |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e318202226c44321ab0d1805baa94b42 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Monoclonal Antibody Therapies for High Risk Neuroblastoma
por: Furman WL
Publicado: (2021) -
A mouse monoclonal antibody against influenza C virus attenuates acetaminophen-induced liver injury in mice
por: Yutaka Sasaki, et al.
Publicado: (2021) -
Aquaporin 4 inhibition alleviates myocardial ischemia-reperfusion injury by restraining cardiomyocyte pyroptosis
por: Qiong Jiang, et al.
Publicado: (2021) -
Emerging Monoclonal Antibody Therapy for the Treatment of Acute Lymphoblastic Leukemia
por: Abuasab T, et al.
Publicado: (2021) -
Using Monoclonal Antibody Therapies for Multiple Sclerosis: A Review
por: Elsbernd PM, et al.
Publicado: (2021)